GlassScriptPhysician profile
Joseph J King
NPI 1356501332
$163,537.55
in general payments reported to CMS, 2019-2025
11 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $2,948 · 2021: $26K · 2022: $46K · 2023: $46K · 2024: $16K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $63K · Food and Beverage: $4,831 · Travel and Lodging: $4,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $63,095.05 |
| Food and Beverage | $4,830.88 |
| Travel and Lodging | $4,237.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $143,418.93 | 2019-2025 | |
| Linkbio Corp | $18,563.61 | 2021-2025 | |
| Stryker Corporation | $361.53 | 2019-2024 | Tornier Perform Anatomic Augmented Glenoid |
| Linvatec Corporation | $228.12 | 2019-2025 | Biobrace 23mm, Linvatec Shoulder Arthroscopy |
| Arthrex, INC. | $213.42 | 2019-2022 | |
| Smith+Nephew, INC. | $181.32 | 2024 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $177.93 | 2019 | |
| Cgg Medical INC | $134.50 | 2025 | |
| Catalyst Orthoscience | $116.41 | 2022 | |
| Encore Medical, LP | $113.52 | 2025 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $28.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.